XML 47 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information (Tables)
9 Months Ended
Mar. 28, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The below tables show select financial measures by reporting segment (in millions):
 
Three Months Ended
 
Balance at March 28, 2015
 
March 28, 2015
 
 
Net Sales
 
Operating Income (Loss)
 
Amortization of Intangibles
 
Total Assets
Consumer Healthcare
$
537.3

 
$
91.8

 
$
8.6

 
$
6,143.3

Nutritionals
129.9

 
11.2

 
7.2

 
1,037.8

Rx Pharmaceuticals
251.6

 
100.0

 
18.3

 
2,605.9

API
30.7

 
10.5

 
0.5

 
252.2

Specialty Sciences
81.9

 
5.5

 
72.8

 
6,055.8

Other
17.7

 
1.3

 
0.4

 
87.8

Unallocated expenses

 
(21.1
)
 

 

Total
$
1,049.1

 
$
199.2

 
$
107.8

 
$
16,182.8


 
Three Months Ended (1)
Balance at March 29, 2014
 
March 29, 2014
 
Net Sales
 
Operating Income (Loss)
 
Amortization of Intangibles
 
Total Assets
Consumer Healthcare
$
537.3

 
$
84.4

 
$
5.3

 
$
2,555.2

Nutritionals
137.8

 
7.3

 
7.3

 
1,011.5

Rx Pharmaceuticals
223.4

 
77.0

 
17.5

 
1,985.4

API
32.0

 
6.8

 
0.5

 
286.8

Specialty Sciences
53.4

 
(54.5
)
 
76.4

 
7,799.5

Other
20.2

 
0.8

 
0.4

 
104.4

Unallocated expenses

 
(18.5
)
 

 

Total
$
1,004.2

 
$
103.3

 
$
107.4

 
$
13,742.8

 
Nine Months Ended
 
March 28, 2015
 
Net Sales
 
Operating Income (Loss)
 
Amortization of Intangibles
Consumer Healthcare
$
1,560.2

 
$
232.0

 
$
26.0

Nutritionals
385.7

 
26.9

 
21.6

Rx Pharmaceuticals
722.8

 
274.4

 
53.3

API
85.5

 
24.9

 
1.5

Specialty Sciences
260.4

 
29.8

 
218.4

Other
57.7

 
3.4

 
1.1

Unallocated expenses

 
(70.7
)
 

Total
$
3,072.3

 
$
520.7

 
$
321.9

 
Nine Months Ended (1)
 
March 29, 2014
 
Net Sales
 
Operating Income (Loss)
 
Amortization of Intangibles
Consumer Healthcare
$
1,612.1

 
$
263.8

 
$
15.9

Nutritionals
406.6

 
28.3

 
22.1

Rx Pharmaceuticals
673.6

 
260.5

 
55.2

API
105.2

 
37.4

 
1.6

Specialty Sciences (2)
60.8

 
(73.5
)
 
85.0

Other
58.3

 
2.6

 
1.3

Unallocated expenses

 
(149.7
)
 

Total
$
2,916.6

 
$
369.5

 
$
181.1


(1) Amounts may not foot due to rounding.
(2) Specialty Sciences represents activity for the period beginning on December 18, 2013 and ending March 29, 2014.